Skip to main content
. Author manuscript; available in PMC: 2016 May 31.
Published in final edited form as: Cell Rep. 2016 May 5;15(7):1394–1400. doi: 10.1016/j.celrep.2016.04.024

Figure 2. Endogenous glucose production after metformin treatment in prediabetic individuals.

Figure 2

(A) EGP during basal, glucagon-deficient (somatostatin), and glucagon-stimulated conditions (glucagon). (B) Fasted plasma glucagon. (C) Relationship between the change in basal EGP to basal, fasting glucagon after metformin. (C). The difference in EGP (Δ EGP) during glucagon-deficient (somatostatin) and glucagon-stimulated (glucagon) versus basal EGP. *P<0.05 metformin vs. placebo; Data presented as mean ± SEM.